Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: A comparative study

Critical Care Medicine

Volumn 40, Issue 2, 2012, Pages 594-602

  Sanchez Peña, Paola ^a   Nouet, Aurélien ^a   Clarençon, Frédéric ^a   Colonne, Chantal ^a   Jean, Betty ^a   Le Jean, Lise ^a   Fonfrede, Michèle ^a   Aout, Mounir ^b   Vicaut, Eric ^b   Puybasset, Louis ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

aneurysmal subarachnoid hemorrhage; atorvastatin; outcome; S100 protein; surrogate marker

Indexed keywords

ATORVASTATIN; MILRINONE; NIMODIPINE; PROTEIN S 100;

ADULT; AGED; ANEURYSM CLIP; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; BRAIN VASOSPASM; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SYMPTOM;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HEPTANOIC ACIDS; HOSPITALS, UNIVERSITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PYRROLES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; S100 PROTEINS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84856145965     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822f05e7     Document Type: Article

References (58)

1. Origitano TC, Wascher TM, Reichman OH, et al: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ('triple-H' therapy) after sub-arachnoid hemorrhage. Neurosurgery 1990; 27:729-739; discussion 739-740
2. Pickard JD, Murray GD, Illingworth R, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. BMJ 1989; 298:636-642
3. Liu JK, Couldwell WT: Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care 2005; 2:124-132
4. Biondi A, Ricciardi GK, Puybasset L, et al: Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Preliminary results. AJNR Am J Neuroradiol 2004; 25:1067-1076
5. Feng L, Fitzsimmons BF, Young WL, et al: Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: Safety and 2-year experience. AJNR Am J Neuroradiol 2002; 23:1284-1290
6. Arakawa Y, Kikuta K, Hojo M, et al: Milrinone reduces cerebral vasospasm after subarachnoid hemorrhage of WFNS grade IV or V. Neurol Med Chir (Tokyo) 2004; 44: 393-400; discussion 401
7. Zuccarello M: Endothelin: The 'prime suspect' in cerebral vasospasm. Acta Neurochir Suppl 2001; 77:61-65
8. Pluta RM: Delayed cerebral vasospasm and nitric oxide: Review, new hypothesis, and proposed treatment. Pharmacol Ther 2005; 105:23-56
9. Vajkoczy P, Meyer B, Weidauer S, et al: Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: Results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 2005; 103:9-17
10. Macdonald RL, Kassell NF, Mayer S, et al: Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008; 39:3015-3021
11. Thomas DD, Miranda KM, Espey MG, et al: Guide for the use of nitric oxide (NO) donors as probes of the chemistry of NO and related redox species in biological systems. Methods Enzymol 2002; 359:84-105
12. O'Driscoll G, Green D, Taylor RR: Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95:1126-1131
13. Lynch JR, Wang H, McGirt MJ, et al: Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 2005; 36: 2024-2026
14. Tseng MY, Czosnyka M, Richards HRS, et al: Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36:1627-1632
15. Tseng MY, Hutchinson PJ, Czosnyka M, et al: Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38:1545-1550
16. Jaschinski U, Scherer M, Lichtwarck M, et al: Impact of treatment with Pravastatin on delayed ischemic disease and mortality after aneurysmal subarachnoid hemorrhage. 28th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2008; 12(Suppl 2):P112
17. Macedo S, Bello Y, Silva A, et al: Effects of simvastatin in prevention of vasospasm in nontraumatic subarachnoid hemorrhage: Preliminary data. 28th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2009; 13(Suppl 1):P103
18. Parra A, Kreiter KT, Williams S, et al: Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: A matched controlled cohort study. Neurosurgery 2005; 56: 476-484; discussion 476-484
19. McGirt MJ, Blessing R, Alexander MJ, et al: Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg 2006; 105:671-674
20. McGirt MJ, Garces Ambrossi GL, Huang J, et al: Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: A singleinstitution prospective cohort study. J Neurosurg 2009; 110:968-974
21. Kern M, Lam MM, Knuckey NW, et al: Statins may not protect against vasospasm in subarachnoid haemorrhage. J Clin Neurosci 2009; 16:527-530
22. Kramer AH, Gurka MJ, Nathan B, et al: Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 2008; 62: 422-427; discussion 427-430
23. Singhal AB, Topcuoglu MA, Dorer DJ, et al: SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 2005; 64:1008-1013
24. Kerz T, Victor A, Beyer C, et al: A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: Incidence of delayed cerebral ischemia and mortality. Neurol Res 2008; 30:893-897
25. Vergouwen MD, Meijers JC, Geskus RB, et al: Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 2009; 29:1444-1453
26. Chou SH, Smith EE, Badjatia N, et al: A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 2008; 39:2891-2893
27. Sillberg VA, Wells GA, Perry JJ: Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: A meta-analysis. Stroke 2008; 39:2622-2626
28. Vergouwen MD, de Haan RJ, Vermeulen M, et al: Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage. A systematic review and meta-analysis update. Stroke 2010; 41:e47-e52
29. Kramer AH, Fletcher JJ: Statins in the management of patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. Neurocrit Care 2010; 12: 285-296
30. Sandercock P: 'Yes' or 'no' to routine statins after subarachnoid hemorrhage to prevent delayed cerebral ischaemia, vasospasm, and death? A cautionary tale of 2 meta-analyses. Stroke 2010; 41:e1-e2
31. Rabinstein AA: Vasospasm and statin therapy: Yet another cautionary tale. Neurocrit Care 2010; 12:310-312
32. Unden J, Bellner J, Reinstrup P, et al: Serial S100B levels before, during and after cerebral herniation. Br J Neurosurg 2004; 18: 277-280
33. Drake C: Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988; 68:985-986
34. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6:1-9
35. International Subarachnoid Aneurysm trial (ISAT) Collaborative Group: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients ruptured intracranial aneurysms: A randomised trial. Lancet 2002; 360:1267-1274
36. Korinek AM, Reina M, Boch AL, et al: Prevention of external ventricular drain-related ventriculitis. Acta Neurochir (Wien) 2005; 147:39-46
37. Okada Y, Shima T, Nishida M, et al: Comparison of transcranial Doppler investigation of aneurysmal vasospasm with digital subtraction angiographic and clinical findings. Neurosurgery 1999; 45:3
38. Arakawa Y, Kikuta K, Hojo M, et al: Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: Report of seven cases. Neurosurgery 2001; 48:723-728; discussion 728-730
39. Weiss N, Sanchez-Peña P, Roche S, et al: Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology 2006; 104:658-666
40. Corsini A: Statin-related muscle complaints: An underestimated risk. Cardiovasc Drugs Ther 2005; 19:379-381
41. Ovbiagele B, Saver JL, Starkman S, et al: Statin enhancement of collateralization in acute stroke. Neurology 2007; 68:2129-2131
42. Ishikawa M, Kusaka G, Yamaguchi N, et al: Platelet and leukocyte adhesion in the microvasculature at the cerebral surface immediately after subarachnoid hemorrhage. Neurosurgery 2009; 64:546-553; discussion 553-554
43. McGirt MJ, Lynch JR, Parra A, et al: Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33:2950-2956
44. Tseng MY, Hutchinson PJ, Turner CL, et al: Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: A double-blind, placebocontrolled trial. J Neurosurg 2007; 107: 1092-1100
45. McGirt MJ, Lynch JR, Blessing R, et al: Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2002; 51: 1128-1134; discussion 1134-1135
46. Wu H, Lu D, Jiang HRS, et al: Simvastatinmediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 2008; 25: 130-139
47. Bulsara KR, Coates JR, Agrawal VK, et al: Effect of combined simvastatin and cyclosporine compared with simvastatin alone on cerebral vasospasm after subarachnoid hemorrhage in a canine model. Neurosurg Focus 2006; 21:E11
48. Vaughan CJ, Delanty N: Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999; 30:1969-1973
49. Sawada N, Liao JK: Targeting eNOS and beyond: Emerging heterogeneity of the role of endothelial Rho proteins in stroke protection. Exp Rev Neurother 2009; 9:1171-1186
50. Bianchi R, Adami C, Giambanco I, et al: S100B binding to RAGE in microglia stimulates COX-2 expression. J Leukoc Biol 2007; 81:108-118
51. Donato R: RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins. Curr Mol Med 2007; 7:711-724
52. Xia W, Han J, Huang G, et al: Inflammation in ischemic brain injury: Current advances and future perspectives. Clin Exp Pharmacol Physiol 2010; 37:253-258
53. Moritz S, Warnat J, Bele S, et al: The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. J Neurosurg Anesthesiol 2010; 22:21-31
54. Kleindienst A, Ross Bullock M: A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma 2006; 23:1185-1200
55. Stranjalis G, Korfias S, Psachoulia C, et al: The prognostic value of serum S-100B protein in spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien) 2007; 149: 231-237; discussion 237-238
56. Pereira AR, Sanchez-Pena P, Biondi A, et al: Predictors of 1-year outcome after coiling for poor-grade subarachnoid aneurysmal hemorrhage. Neurocrit Care 2007; 7:18-26
57. Kaneda K, Fujita M, Yamashita S, et al: Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients. Brain Res Bull 81:173-177
58. Oertel M, Schumacher U, McArthur DL, et al: S-100B and NSE: Markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. J Clin Neurosci 2006; 13:834-840